Strip of 10 Units
MRP ₹309.7
₹257.95
₹30.97/Units
Use current location
Login to view saved addresses
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
CompositionBladmir-25 Tablet is used to treat symptoms of an overactive bladder (OAB), such as frequent urination, sudden urges to urinate, and urge urinary incontinence. This medicine belongs to a group known as beta-3 adrenergic receptor agonists (containing Mirabegron 25 mg). It works by relaxing the bladder muscles, which increases the amount of urine the bladder can hold and reduces the spasms, offering convenient, once-daily symptomatic relief.
Bladmir-25 Tablet is used to manage symptoms of overactive bladder in adults. It reduces frequent urination, helps control sudden urges to urinate, and alleviates urge incontinence, which involves involuntary leakage of urine.
Here's how to take Bladmir-25 Tablet correctly:
Swallow the tablet whole with a glass of water.
Do not chew, crush or divide the tablet.
It's crucial not to exceed the recommended dose without consulting your doctor.
Remember, never stop taking this medicine without discussing it with your doctor first.
Bladmir-25 Tablet is taken orally.
Bladmir-25 Tablet may cause hypertension (high blood pressure), nasopharyngitis (common cold), urinary tract infection, headache, dry mouth, constipation, and dizziness.
Most side effects are temporary and generally harmless, which resolve upon discontinuing the use of Bladmir-25 Tablet. However, if you experience any serious side effects or worsening of any of the symptoms, please consult your doctor.
Here are some general guidelines for managing common side effects:
Constipation: Increase your fibre intake and consume plenty of water.
Dizziness: Consider taking this medicine at night if it causes you light-headedness during the day.
Bladmir-25 Tablet contains mirabegron (25 mg) which acts on your body as follows:
Beta-3 adrenergic receptor activation: Mirabegron works by activating the beta-3 adrenergic receptors in your body. These receptors are mainly found in the detrusor muscle of the bladder.
Relaxation of the detrusor muscle: By activating these receptors, mirabegron helps relax the detrusor muscle of the bladder during the storage phase of the bladder fill-void cycle. This relaxation leads to an increase in bladder capacity.
Reduction in OAB symptoms: By increasing bladder capacity, mirabegron effectively reduces the frequency of urination, urgency episodes, and instances of incontinence, common symptoms of overactive bladder.
Bladmir-25 Tablet should be used with caution during pregnancy. It's recommended to consult your doctor before taking this medicine.
Bladmir-25 Tablet is not advised for use while breastfeeding. Discuss possible risks and benefits with your doctor before starting this medication.
There is no known interaction between Bladmir-25 Tablet and alcohol. However, always consult your doctor for guidance.
If you have mild to moderate liver impairment, be cautious while taking Bladmir-25 Tablet. This medication isn't recommended for severe liver diseases. Discuss any liver-related concerns with your doctor before starting the medicine.
Caution is advised if you have a history of kidney problems before using Bladmir-25 Tablet. It's best to consult your doctor before taking this medicine.
Taking Bladmir-25 Tablet might affect your ability to drive or operate machinery due to potential side effects like dizziness. Always ensure you know how you react to this medicine before driving or operating heavy machinery.
If you're allergic to mirabegron or any other excipients in Bladmir-25 Tablet, do not take this medicine. Always inform your doctor about any allergies before starting the medication.
The safety and efficacy of Bladmir-25 Tablet haven't been established in children under 18 years of age. Consult your doctor before giving this medicine to a child.
Elderly patients should take Bladmir-25 Tablet under medical supervision as they may be more susceptible to its side effects. Caution is advised especially for patients above 70 years of age, who may also have liver and kidney issues or might be on other medication. Your doctor will guide you based on your overall health status.
Bladmir-25 Tablet interacts with the following medicines:
Beta-adrenergic antagonists: Co-administration with beta-blockers (e.g., propranolol) can increase the risk of hypertension due to additive effects on blood pressure.
Heart medications: When starting a combination treatment with Bladmir-25 Tablet and digoxin, careful monitoring of serum digoxin levels is necessary to avoid potential side effects.
Antimuscarinic medications: Using Bladmir-25 Tablet in combination with antimuscarinic medications like tolterodine for overactive bladder may increase the risk of urinary retention.
No specific food interactions have been reported with Bladmir-25 Tablet.
Bladmir-25 Tablet interacts with the following diseases:
Severe Renal Impairment: Those suffering from severe renal impairment (eGFR 15 to 29 mL/min/1.73 m2) should take a maximum dose of 25 mg once daily of Bladmir-25 Tablet.
Moderate Hepatic Impairment: In patients with moderate hepatic impairment (Child-Pugh Class B), it's advisable to limit the daily dose of Bladmir-25 Tablet to 25 mg.
Severe Uncontrolled Hypertension: People with severe uncontrolled hypertension should use Bladmir-25 Tablet with caution due to its potential to increase blood pressure.
The daily dosage of Bladmir-25 Tablet should be as per your doctor's prescription. The prescribed dosage may vary based on factors like the severity of your condition and how you respond to the medication. Always adhere to the prescribed dosage and never alter it without consulting your doctor.
Overdosing on Bladmir-25 Tablet may lead to increased heart rate and blood pressure. If you've taken more than your prescribed dose, don't panic, but do inform your doctor about it.
If you miss a dose of Bladmir-25 Tablet, take it as soon as you remember. However, if it's nearly time for your next dose, skip the missed one and continue with your regular dosage schedule. Never modify your dosage without consulting your doctor.
Keep Bladmir-25 Tablet in its original packaging to shield it from light and moisture.
Store at room temperature, ideally below 30°C.
Ensure the medicine is out of reach of children.
Use the medicine before its expiry date.
Since Bladmir-25 Tablet helps manage overactive bladder symptoms, incorporate bladder-friendly foods into your diet. This includes high-fibre foods like whole grains, fruits, and vegetables that can prevent constipation and ease the pressure on your bladder.
Limit intake of bladder irritants such as caffeine, alcohol, and spicy foods which can aggravate overactive bladder symptoms. Consult your doctor for more specific dietary advice.
| Available Dosage Types | Tablet |
| Habit Forming | No |
| Ailment | Overactive Bladder, Urinary Incontinence, Urinary Urgency |
| Drug Category | Beta-3 Adrenergic Agonist |
| Therapeutic Category | Urinary System Agent |
It's a medicine that manages overactive bladder (OAB) symptoms such as sudden urges to urinate, frequent urination, and sometimes, involuntary leakage of urine.
It contains mirabegron which relaxes the bladder muscles, increasing its capacity and reducing OAB symptoms like urinary frequency and urgency.
No, you should swallow the tablet whole with water. Crushing or chewing may disrupt its extended-release properties.
Some users may experience high blood pressure, common cold symptoms, urinary tract infections, or headaches. Always consult your doctor if you have side effects.
Mirabegron is not generally recommended during pregnancy unless the benefit outweighs the risk. Always consult your doctor before taking any medicine during pregnancy.
Elderly patients should take Bladmir-25 Tablet under medical supervision as they may be more susceptible to its side effects. Caution is advised especially for patients above 70 years of age, who may also have liver and kidney issues or might be on other medication.
Combining it with other OAB medicines hasn't been thoroughly evaluated for safety. Consult your doctor before starting any combination therapy.
Check out Editorial Policy
Astellas Pharma US, Inc. (2012). HIGHLIGHTS OF PRESCRIBING INFORMATION [Press release]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202611s000lbl.pdf
Betmiga. (n.d.). Betmiga Summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/betmiga-epar-product-information_en.pdf
Dawood, O., & El-Zawahry, A. (2023, August 28). Mirabegron. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK538513/
PubChem. (n.d.). Mirabegron. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Mirabegron
Mirabegron: Uses, interactions, mechanism of action | DrugBank Online. (n.d.). DrugBank. https://go.drugbank.com/drugs/DB08893
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
50.1% CHEAPER
900 + users bought this instead
Read More
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaAll MedicinesAll BrandsNeed HelpFAQSecuritySubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.8.2
2025 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
